Skip to content

Drug interactions

Armodafinil + Belumosudil

Severity: Moderate

Armodafinil and Belumosudil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Belumosudil is metabolised mainly by CYP3A4, and armodafinil may induce this enzyme. Belumosudil exposure may fall, potentially lowering efficacy in chronic graft-versus-host disease. The expected effect is modest.

What this interaction means in plain words

Armodafinil and Belumosudil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Armodafinil belongs to Central Nervous System; Belumosudil belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 induction by armodafinil, increasing belumosudil clearance.

What to do

Monitor clinical response of graft-versus-host disease. Consider an alternative to armodafinil if response is lost.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Belumosudil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Belumosudil?

MediHelp rates the interaction as moderate. Armodafinil and Belumosudil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Belumosudil is metabolised mainly by CYP3A4, and armodafinil may induce this enzyme. Belumosudil exposure may fall, potentially lowering efficacy in chronic graft-versus-host disease. The expected effect is modest.

How serious is the interaction between Armodafinil and Belumosudil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response of graft-versus-host disease. Consider an alternative to armodafinil if response is lost.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Cyclosporine, Elacestrant. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in